WGS Latest Press Releases

-- May 11, 2026 --

WGS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations Globe Newswire 8:00 PM

-- May 9, 2026 --

GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm Globe Newswire 9:50 AM

-- May 7, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS PRNewswire 7:01 PM

Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud Globe Newswire 9:30 AM

-- May 6, 2026 --

GENEDX HOLDINGS CORP. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud Business Wire 8:00 PM

INVESTOR ALERT: Investigation of GeneDx Holdings Corp. (WGS) announced by Holzer & Holzer, LLC Globe Newswire 3:04 PM

Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Business Wire 12:00 PM

GeneDx Holdings Corp. (WGS) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation Business Wire 9:00 AM

-- May 5, 2026 --

WGS: GeneDX Shares Plummet Over 45%; Investors Should Contact Block & Leviton to Potentially Recover Money Through The Firm's Investigation Globe Newswire 6:11 PM

Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced - Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz Business Wire 3:33 PM

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GeneDx Holdings Corp. PRNewswire 2:58 PM

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 8:09 AM

-- May 4, 2026 --

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook Business Wire 4:05 PM

-- April 13, 2026 --

GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026 Business Wire 4:05 PM

-- March 11, 2026 --

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing Business Wire 5:00 PM

-- March 10, 2026 --

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C Business Wire 8:30 AM

-- March 9, 2026 --

GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity and Real-World Genomic Leadership Business Wire 8:30 AM

-- February 25, 2026 --

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PRNewswire 8:03 PM

GeneDx to Participate in Upcoming Investor Conferences Business Wire 8:30 AM

-- February 23, 2026 --

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026 Business Wire 6:30 AM

-- February 11, 2026 --

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health Business Wire 9:05 AM

-- February 3, 2026 --

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 Business Wire 8:00 AM

-- January 15, 2026 --

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights Business Wire 11:24 AM

-- January 12, 2026 --

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance Business Wire 7:30 AM

-- January 8, 2026 --

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset Business Wire 8:30 AM

-- January 7, 2026 --

GeneDx Announces GenomeDx Prenatal , Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care Business Wire 8:30 AM

-- January 6, 2026 --

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care Business Wire 8:30 AM

-- January 5, 2026 --

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025 Business Wire 8:30 AM

-- December 30, 2025 --

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference Business Wire 8:00 AM

-- December 15, 2025 --

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year Business Wire 8:30 AM